Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Shanghai Heartcare Medical Technology Corp. Ltd. Class H ( (HK:6609) ).
Shanghai HeartCare Medical Technology Corporation Limited announced a positive profit alert, expecting a net profit of not less than RMB40 million for the first half of 2025, marking a significant turnaround from a net loss in the same period of 2024. This improvement is attributed to business growth and a decrease in the expense ratio. Additionally, the company proposes to utilize its capital reserve to offset losses, pending shareholder approval at an upcoming extraordinary general meeting.
More about Shanghai Heartcare Medical Technology Corp. Ltd. Class H
Shanghai HeartCare Medical Technology Corporation Limited is a company incorporated in China, operating in the medical technology industry. It focuses on developing and providing medical solutions and technologies, with a market focus on healthcare advancements.
Average Trading Volume: 133,751
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.05B
For detailed information about 6609 stock, go to TipRanks’ Stock Analysis page.